Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
1.77 (1y: -42%)
Market Cap 31.87 M P/E(ttm)
Enterprise Value 32.96 M P/B
IPCI- NAS (USA)
IntelliPharmaCeutics International, Inc.
Not Rated
Top Ranked Predictable Companies
$1.77
Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry		 vs
history
Cash to Debt 5.071
IPCI's Cash to Debt is ranked lower than
62% of the 349 Companies
in the Global Biotechnology industry.

( Industry Median: 10000.00 vs. IPCI: 5.071 )
IPCI' s 10-Year Cash to Debt Range
Min: 5.07   Max: No Debt
Current: 5.07
Equity to Asset -0.714
IPCI's Equity to Asset is ranked lower than
95% of the 349 Companies
in the Global Biotechnology industry.

( Industry Median: 0.54 vs. IPCI: -0.714 )
IPCI' s 10-Year Equity to Asset Range
Min: -0.71   Max: 0.93
Current: -0.71
-0.71
0.93
F-Score: 2
Z-Score: -5.13
M-Score: -6.61319e+13
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry		 vs
history
Operating margin (%) -9455.10
IPCI's Operating margin (%) is ranked lower than
86% of the 349 Companies
in the Global Biotechnology industry.

( Industry Median: -52.55 vs. IPCI: -9455.10 )
IPCI' s 10-Year Operating margin (%) Range
Min: -1046100   Max: -414.8
Current: -9455.1
-1046100
-414.8
Net-margin (%) -5735.5
IPCI's Net-margin (%) is ranked lower than
85% of the 349 Companies
in the Global Biotechnology industry.

( Industry Median: -55.70 vs. IPCI: -5735.5 )
IPCI' s 10-Year Net-margin (%) Range
Min: -914800   Max: -394.9
Current: -5735.5
-914800
-394.9
ROA (%) -248
IPCI's ROA (%) is ranked lower than
91% of the 349 Companies
in the Global Biotechnology industry.

( Industry Median: -14.40 vs. IPCI: -248 )
IPCI' s 10-Year ROA (%) Range
Min: -248   Max: -22.2
Current: -248
-248
-22.2
EBITDA Growth (%) -64.3
IPCI's EBITDA Growth (%) is ranked higher than
54% of the 349 Companies
in the Global Biotechnology industry.

( Industry Median: -11.35 vs. IPCI: -64.3 )
IPCI' s 10-Year EBITDA Growth (%) Range
Min: -64.3   Max: 6.7
Current: -64.3
-64.3
6.7
» IPCI's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

IPCI Guru Trades in

IPCI Guru Trades in

IPCI Guru Trades in

Q2 2011

IPCI Guru Trades in Q2 2011

Jim Simons Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with IPCI



No Insider Trades Found!

Ratios

vs
industry		 vs
history
P/S 90.00
IPCI's P/S is ranked lower than
93% of the 349 Companies
in the Global Biotechnology industry.

( Industry Median: 6.90 vs. IPCI: 90.00 )
IPCI' s 10-Year P/S Range
Min: 0.15   Max: 259.09
Current: 90
0.15
259.09
EV-to-EBIT -7.26
IPCI's EV-to-EBIT is ranked lower than
83% of the 349 Companies
in the Global Biotechnology industry.

( Industry Median: 14.61 vs. IPCI: -7.26 )
IPCI' s 10-Year EV-to-EBIT Range
Min: 0   Max: 0
Current: -7.26

Valuation & Return

vs
industry		 vs
history

Business Description

IntelliPharmaCeutics International, Inc. was incorporated under the Canada Business Corporations Act by certificate and articles of arrangement dated October 22, 2009. The company engages in the research, development, and manufacture of novel or generic controlled and targeted release oral solid dosage drugs. The company's patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of various existing and new pharmaceuticals. It has a pipeline of products in various stages of development in therapeutic areas, including neurology, cardiovascular, and gastrointestinal tract, pain, and infection. The company's lead generic product under development includes generic Focalin XR (dexmethylphenidate hydrochloride), an extended-release capsule for the treatment of attention deficit hyperactivity disorder. The company has a license and commercialization agreement with Par Pharmaceutical, Inc. for the development and commercialization of generic Focalin XR. The company also has five generic products filed with the FDA, including a generic of Effexor XR (venlafaxine hydrochloride), an extended-release capsule for depression; Protonix (pantoprazole sodium), a delayed-release tablet for conditions associated with gastroesophageal disease; Glucophage XR (metformin hydrochloride), an extended-release tablet for managing type 2 diabetes; Seroquel XR (quetiapine fumarate), an extended-release tablet for the treatment of schizophrenia, bipolar disorder, and major depressive disorder; and Lamictal XR (lamotrigine), an extended-release tablet for the treatment of anti-convulsant for epilepsy.
Company Website
Industry: Biotechnology
Compare:NVO, AMGN, GILD, BIIB, CELG
Traded in other countries:I.Canada

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial